Rhenman & Partners Asset Management AB

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1599882 Stockholm, V7

Position in MIRM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$8,554,849

+$161,767 QoQ

Shares Held

92,605

-12.8% QoQ

Ownership

0.152%

of shares outstanding

% of Portfolio

1.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. MIRM ranks #12 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	48,100	$37,163,984
2	INSM	INSMED Inc	159,760	$26,123,955
3	VRTX	Vertex Pharmaceuticals Inc / Ma	43,485	$19,417,791
4	JAZZ	Jazz Pharmaceuticals plc	75,890	$14,347,004
5	MDGL	Madrigal Pharmaceuticals, Inc.	24,050	$12,589,453
6	BMRN	Biomarin Pharmaceutical Inc	207,000	$11,693,430
7	ALNY	Alnylam Pharmaceuticals, Inc.	34,465	$11,403,434
8	RPRX	Royalty Pharma plc	233,000	$11,177,010

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,554,849	92,605	-12.8%	Shares	Sole	2026-05-14
2025-12-31	$8,393,082	106,255	+88.9%	Shares	Sole	2026-02-13
2025-09-30	$4,124,054	56,255	-14.4%	Shares	Sole	2025-11-13
2025-06-30	$3,346,271	65,755	-10.8%	Shares	Sole	2025-08-13
2025-03-31	$3,322,662	73,755	0.0%	Shares	Sole	2025-05-14
2024-12-31	$3,049,769	73,755	-29.8%	Shares	Sole	2025-02-13
2024-09-30	$4,095,000	105,000	-21.8%	Shares	Sole	2024-11-13
2024-06-30	$4,590,007	134,250	+45.5%	Shares	Sole	2024-08-13
2024-03-31	$2,317,320	92,250	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.